Home » Newsletters » BioWorld Science

BioWorld Science

May 14, 2014

View Archived Issues

BACE1 inhibitor tested for retinal beta-amyloidosis

Safety and efficacy of anti-CHST15 dsRNA in patients with Crohn's disease

GeneSight pharmacogenomic test improves odds of response to antidepressants

Mitsubishi Tanabe Pharma reflects on accomplishments of fiscal 2013

BTZ-169 demonstrates significant efficacy for N. brasiliensis infection

Researchers present promising in vitro data for VCP-746

Dainippon Sumitomo Pharma offers overview of fiscal 2013

Excellagen selected for use with stem cells in E.U.-funded human study

Shin Poong's neuroprotective compound shows promising preclinical results

Jubilant Biosys and Orion form collaborative pain management program

Kythera Biopharmaceuticals submits ATX-101 NDA for submental fat reduction

MabVax Therapeutics and Telik agree to merge

Origenis researchers patent new protein kinase inhibitors

Roche discloses novel Abeta production inhibitors

Berg and Medical University of South Carolina form collaboration to discover lupus biomarkers

Janssen presents novel antivirals for RSV infection

Abbott reports results for investigational infection diagnostic

New agents for HCV infection disclosed by Merck & Co.

Aslan Pharmaceuticals and CSL to develop new therapy for asthma

Janssen submits sNDAs to FDA for Invega Sustenna

FDA clears transfer of orphan drug designation for intrathecal resiniferatoxin to Sorrento

Inovio acquires rights to preclinical therapies for Alzheimer's and MS

Lysosomal Therapeutics receives funding for neurodegenerative disease research

Xenetic Biosciences reports phase I results for oxyntomodulin analogue

Incyte and MedImmune to collaborate on cancer immunotherapy combination trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...